Genomic Health Inc. Message Board
-
They are definitely activist investors. Look at what happened with XOMA. They virtually control the company now, and came in after a wicked reverse stock split, when the co was super cheap.
Sentiment: Strong Buy
-
Yep, all the doubters out there, bitter and long-suffering longs, will eventually see an end to their pain. In two years this will be a $15 stock, if it doesn't get bought out before that. The Baker Bros. are very intelligent investors; average holding period is 3-5 years. But, they virtually control this company, so they are in the driver's seat. When the pps hits $5 mutual funds will begin to accumulate, and due to the low float the pps will climb nicely.
Sentiment: Strong Buy
-
He actually does his homework on trial design, and downstream data, and he's willing to listen to other's expert opinion, even if it differs from his. He's overly vilified, imo, but is also in the bull camp on SRPT, even though he's forbidden from trading or owning stocks, due to conflict of interest.
Sentiment: Strong Buy
-
This individual is simply stirring the pot and is probably a basher for hire. I got that you were speculating, and simply agreed with you. Mr. "cansomeone...." jumped ugly to be manipulative. Although it's highly unlikely that anyone on this board really has any influence on the share price, or the large core investor sentiment.
Sentiment: Strong Buy
-
I agree with you on "fast track" application. I think when FDA was satisfied with the data on Ph. III trial, due to safety and efficacy, they opened the door for fast tracking pimavanserin.
Sentiment: Strong Buy
-
Their dept. of computer generated sell-side ideas put a "sell" on the featured laggard, ACAD, after the market closed yesterday due to, among other things, "The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and feeble growth in its earnings per share." Never mind that ACAD owns world-wide rights to pimavanserin, and it has better efficacy than the leading antipsychotics AND a better safety profile. It's not the revenue they are currently generating, but future revenue they will likely make that counts.
Sentiment: Strong Buy
- Reply to
Baker Bros Bought 13 MIL in Dec. in $7's Make Sense They Sell Now.
by going1green •Apr 30, 2013 10:44 AMBaker Bros. average holding time for a stock is 3-5 years. They understand value and do their homework, and they are not "traders".
Sentiment: Strong Buy
- Reply to
My guess is sec investigation into insider sales
by cansomeonetellmenowpls •Apr 30, 2013 11:11 AMI can tell you this: Your post is misleading and manipulative. I can also tell you that further posts by you will be on my 'ignore" list.
Sentiment: Strong Buy
-
The above referenced article was published on 3-5-13 by thestreet. Just google the title and read it. The author (not Adam F. - who is overly vilified) makes an excellent case for the long view of SRPT.
I am unconcerned about the recent pull-back due to FDA's wanting to look at all recent data. If you believe the author's thesis, as I do, you just can't get all lathered up by this recent sell-off, which has been compounded by sell-side analysts holding conference calls, beating the drum for the bear case (more FDA required clinical testing).
And to Bud's T/A work. What about the case for manipulation of share price due to concerted effort by the short crowd, which triggers a "sell signal" when a certain support level has been violated? I've seen this whip-saw effect in biotech happen many times before, where stops get taken out quickly, only to have the shorts cover and the share price recovers. It's a messy industry, with a lot of potential for manipulation. It's just the nature of the beast.Sentiment: Strong Buy
- Reply to
OK - so the only reason this thing is not tankin is: The Fabulous Baker Boys hold approx 30% of the stock.
by tdm1995 •Apr 26, 2013 10:51 PMre: the Baker bros - "But are these guys in any way competent?" Just by making that one statement you have proven yourself to be a complete idiot to all who know their history of success. And as with all idiots, such as yourself, off to the cyber trash can of ignore you go, never to be heard from again. And all your other aka's.
Sentiment: Strong Buy
-
No apologies necessary, Bud. I know a lot of people follow T/A and it has it's merits, but it seems like with so many people charting, including the quant funds, that there's a lot of self-fullfilling prophecy going on here. The levels of support / resistance are always a moving target, above / below trend channels or moving averages, on certain levels of volume.....I get it. I just think that biotech is such a different animal and often times cannot be put in a box with T/A. Look at ACAD. All the T/A folks on that board are all over the map on their reading of the tea leaves. With SRPT, were just going to be range bound, between $27-31 a share until some news is announced for AA (or not), and it could go a lot lower with some major market sell-off. That's the reality with biotech, it always does worse than the market averages when "risk-off" is in play. Unless there's some incredible news that keeps the momo players in high gear.
With all that said, I don't think SRPT is over-sold right now. I think it got way ahead of itself pushing the $40 s.p. and has simply corrected, given the stretched out time line for possible AA. Without any news, the share price is vulnerable to hedge funds trying to push the price down. As you know, there's huge short interest in the stock. Bears and bulls all want to make a killing here. The middle ground won't last forever, but the bears will likely put price pressure on the stock in the interim, every chance they get. It may get oversold soon. We'll see, but you'll only know that in the rear view mirror. GLTASentiment: Strong Buy
- Reply to
Looks to be closing at or near low of the day. Pathetic action over the last 2 weeks
by zwerp2000 •Apr 26, 2013 3:49 PMZwerp2K.......really? What in the world to you expect? There's zero news and it's so typical of biotech, in the absence of any real catalyst to drift lower. The stock is completely behaving as one would expect, under the circumstances. You seem to have some compulsive need to narrate the share price day by day, and engage in verbal hand wringing or just stating the obvious. Let's just say it's tiresome and pointless.
Sentiment: Strong Buy
-
Certainly makes the case for an acceleration of clinical / commercial activity in SRPT sooner, rather than later. Thanks for the post.
Sentiment: Strong Buy
-
What's especially annoying is all the banter of daily / hourly price moves, overstating the obvious weakness, and T/A analysis ad nauseum. Now, we're just going to track the overall biotech sector until meaningful news is released, probably sometime this summer. The FDA, after all, moves at a nearly glacial pace. And so we wait, frustrated bulls and nouveau or just ordinary bears. It's all noise and banter until SRPT makes some significant announcement.
Sentiment: Strong Buy
-
The reality (imo) is that the share price had gotten over-extended, near $40, on the expectation of a smooth filing of AA and all blessings by the FDA. These situations are never that seamless; there are always thorns somewhere.
The current situation appears to be one of stasis; we've reached equilibrium between the bull/bears. In the absence of significant news, we'll probably tread water around these levels (baring major mkt. correction) until the water clears, and AA filing is announced or denied.Sentiment: Strong Buy
- Reply to
From 8K filed on 04/11 - you longs need to read this... this is going down...
by cansomeonetellmenowpls •Apr 24, 2013 8:17 PMI'm sure the Baker Bros. were very aware of timelines and associated hurdles ("remaining elements") prior to filing. Yet... get this....they had a 200% increase from their previous investment, and this was from the year-end 2012 13-F filing, before there was any news out about ACAD getting a pass from the FDA about further Ph III trials. The Baker Bros. occasionally get it wrong, but not often, and not with this much at stake. They know a winner and are willing to wait; I'm just along for the ride.
Sentiment: Strong Buy
-
Okay zwerp2k.......i'm sorry to say that you've reached my tolerance for useless, handwringing posts. time to ignore you.
Sentiment: Strong Buy
-
Hey, it's biotech.....pretty volatile any way you slice it; always has been and always will be. You either stand by your convictions, and don't get all emotional with the noise of fluctuating share price, or you buy big cap stocks that pay a nice dividend. Look at the chart of SGEN. There's been some pretty deep valleys in that chart. Deal with it. BTW, Adam F. will be vindicated.
Sentiment: Strong Buy
-
Always that possibility, or, somebody who bought higher had a margin call. In any case somebody with deep pockets was willing to pony up nearly $4 mil. Them's the facts, no?
Sentiment: Strong Buy
- Reply to
SRPT is selling off because the catalyst is 6 months away
by biocatalysttrader •Apr 23, 2013 10:49 AMThe only way SRPT would test 22/23 again is if the FDA asked for additional testing with a higher number of test subjects on drug, which won't happen. An institutional buy just went through for $4.9 mil That's the smart money loading up. I'm following their lead......adding more.
Sentiment: Strong Buy